- Home
- IPST vs VBIO Comparison
IPST vs VBIO Comparison
Compare IPST & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPST | VBIO |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.6M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IPST | VBIO |
|---|---|---|
| Price | $9.65 | $0.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $164.00 | N/A |
| AVG Volume (30 Days) | 4.3M | ★ 17.6M |
| Earning Date | 04-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,402,488.00 | $780,000.00 |
| Revenue This Year | $70.16 | N/A |
| Revenue Next Year | $60.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $0.24 | $0.11 |
| 52 Week High | $25.34 | $1.30 |
Technical Indicators
Market Signals| Indicator | IPST | VBIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 24.00 |
| Support Level | $1.67 | N/A |
| Resistance Level | $10.68 | $0.44 |
| Average True Range (ATR) | 3.07 | 0.13 |
| MACD | 0.91 | -0.01 |
| Stochastic Oscillator | 32.65 | 0.78 |
Price Performance
Historical ComparisonAbout IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
About VBIO Valion Bio Inc. Common Stock
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.